Kyobo 19 Special Purpose Acquisition교보19호스팩

Kyobo 19 Special Purpose Acquisition is a blank-check shell with no revenue, no merger target named yet, and a share price far below its 52-week high.

This is a special purpose acquisition company (SPAC) listed on KOSDAQ in December 2025, with no operations and no revenue. Its stated purpose is to merge with a private company with proprietary technology, focusing on renewable energy, biopharmaceuticals, medical devices and IT, but the data shows no target has been identified. At ₩1,993 the shares are roughly 37% of the 52-week high of ₩5,440 and close to the 52-week low of ₩1,972.

What stands out

• Trailing twelve-month revenue is zero, with an operating loss of about ₩31.9M and a net loss of about ₩28.0M as of H1 2026.
• Cash of about ₩1.79B is set against borrowings of about ₩1.40B, and liabilities are 13.7% of equity.
• The stock is priced at 1.0 times book value, and the data gives no P/E or P/S because there are no earnings or sales.
• The 20-day investor flows show retail selling of about ₩27.8B against institutional buying of about ₩24.8B, and foreign ownership fell from 0.2% to 0%.
• Filings include several 5%+ holding reports, most recently on 21 October 2026, and the half-year report for June 2026 was filed on 14 August 2026.

What to watch

• Whether the company announces a merger target, which is the only route its business plan describes; the data names none.
• Upcoming filings, including any further 5%+ holding reports and the next quarterly report.
• The company's ability to fund its costs and borrowings while it has no revenue; the data gives no forecasts.